We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MedCision Announces the ThawSTAR Early Adopter Program

Product News   Apr 07, 2017 | Original story from MedCision

 
MedCision Announces the ThawSTAR Early Adopter Program

Credit: MedCision

FURTHER INFORMATION
 
 
 

Related Product News

Preparation Begins For First Clinical Trial of a Bioprinted Skin

Product News

Poietis and the Assistance Publique – Hôpitaux de Marseille have announced that they have entered into a clinical research collaboration contract on a bioprinted tissue engineering product.

READ MORE

The Native Antigen Company Introduces Novel Coronavirus Antigens

Product News

The Native Antigen Company has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain.

READ MORE

Lyndra Therapeutics Files IND, Adds to Leadership Team and Readies for Manufacturing

Product News

Lyndra Therapeutics has filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for its ultra-long-acting oral therapy to treat schizophrenia (risperidone).

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE